NDC 0409-0181

Gemcitabine

Gemcitabine

Gemcitabine is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Gemcitabine Hydrochloride.

Product ID0409-0181_101f43eb-2c3a-4813-8f0f-884a7abcba61
NDC0409-0181
Product TypeHuman Prescription Drug
Proprietary NameGemcitabine
Generic NameGemcitabine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2011-08-26
Marketing CategoryNDA / NDA
Application NumberNDA200795
Labeler NameHospira, Inc.
Substance NameGEMCITABINE HYDROCHLORIDE
Active Ingredient Strength38 mg/mL
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0409-0181-25

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0181-25) > 26.3 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2013-07-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-0181-25 [00409018125]

Gemcitabine INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA200795
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-07-09

NDC 0409-0181-01 [00409018101]

Gemcitabine INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA200795
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2011-08-26

Drug Details

Active Ingredients

IngredientStrength
GEMCITABINE HYDROCHLORIDE38 mg/mL

OpenFDA Data

SPL SET ID:e18ed1cb-7dd0-4001-bfda-17d1f4587fb8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1720975
  • 1720977
  • 1720960
  • Pharmacological Class

    • Nucleic Acid Synthesis Inhibitors [MoA]
    • Nucleoside Metabolic Inhibitor [EPC]

    NDC Crossover Matching brand name "Gemcitabine" or generic name "Gemcitabine"

    NDCBrand NameGeneric Name
    0143-9394GemcitabineGemcitabine
    0143-9395GemcitabineGemcitabine
    0409-0181GemcitabineGEMCITABINE
    0409-0182GemcitabineGEMCITABINE
    0409-0183GemcitabineGEMCITABINE
    0409-0185GemcitabineGEMCITABINE
    0409-0186GemcitabineGEMCITABINE
    0409-0187GEMCITABINEGEMCITABINE
    16714-909GEMCITABINEGEMCITABINE HYDROCHLORIDE
    16714-930GEMCITABINEGEMCITABINE HYDROCHLORIDE
    16729-391GEMCITABINEGEMCITABINE
    16729-419GEMCITABINEGEMCITABINE
    16729-423GEMCITABINEGEMCITABINE
    68001-359GEMCITABINEGEMCITABINE
    68001-348GEMCITABINEGEMCITABINE
    68001-342GEMCITABINEGEMCITABINE
    68001-350GEMCITABINEGEMCITABINE
    70860-205GemcitabineGemcitabine
    70860-204GemcitabineGemcitabine
    71288-113GEMCITABINEGEMCITABINE
    71288-114GEMCITABINEGEMCITABINE
    16729-426GEMCITABINEGEMCITABINE
    25021-239GemcitabineGemcitabine
    25021-234gemcitabinegemcitabine
    25021-235gemcitabinegemcitabine
    45963-624GemcitabineGemcitabine
    45963-623GemcitabineGemcitabine
    45963-636GemcitabineGemcitabine
    50742-498GEMCITABINEGEMCITABINE
    50742-497GEMCITABINEGEMCITABINE
    50742-496GEMCITABINEGEMCITABINE
    55111-686gemcitabinegemcitabine
    55111-687gemcitabinegemcitabine
    55390-391gemcitabinegemcitabine
    60505-6114GemcitabineGemcitabine
    60505-6113GemcitabineGemcitabine
    60505-6115GemcitabineGemcitabine
    63323-102GEMCITABINEGEMCITABINE
    63323-125GEMCITABINEGEMCITABINE
    63323-126GEMCITABINEGEMCITABINE
    67457-618GemcitabineGemcitabine
    67457-617GemcitabineGemcitabine
    67457-616GemcitabineGemcitabine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.